Viewing Study NCT05413551


Ignite Creation Date: 2025-12-24 @ 11:44 PM
Ignite Modification Date: 2025-12-25 @ 9:36 PM
Study NCT ID: NCT05413551
Status: COMPLETED
Last Update Posted: 2025-12-17
First Post: 2022-06-07
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Point-of-care Pharmacogenomic Testing to Optimize Isoniazid Dosing for Tuberculosis Prevention
Sponsor: Stanford University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Tuberculosis Infection View
None Isoniazid Adverse Reaction View
Keywords: